Sam Altman Launches Merge Labs to Rival Neuralink
Sam Altman’s Merge Labs targets Neuralink with AI-powered brain implants, valued at $850M, aiming for high-bandwidth BCI technology backed by OpenAI as neurotechnology competition intensifies.
Read More